Prospective, Multicenter, Controlled Trial of Mobile Stroke Units.

JC, Grotta; JM, Yamal; SA, Parker; SS, Rajan; NR, Gonzales; WJ, Jones; AW, Alexandrov; BB, Navi; M, Nour; I, Spokoyny; J, Mackey; D, Persse; AP, Jacob; M, Wang; N, Singh; AV, Alexandrov; ME, Fink; JL, Saver; J, English; N, Barazangi; PL, Bratina; M, Gonzalez; BD, Schimpf; K, Ackerson; C, Sherman; M, Lerario; S, Mir; J, Im; JZ, Willey; D, Chiu; M, Eisshofer; J, Miller; D, Ornelas; JP, Rhudy; KM, Brown; BM, Villareal; M, Gausche-Hill; N, Bosson; G, Gilbert; SQ, Collins; K, Silnes; J, Volpi; V, Misra; J, McCarthy; T, Flanagan; CPV, Rao; JS, Kass; L, Griffin; N, Rangel-Gutierrez; E, Lechuga; J, Stephenson; K, Phan; Y, Sanders; EA, Noser; R, Bowry

doi:10.1056/nejmoa2103879

Public

Prospective, Multicenter, Controlled Trial of Mobile Stroke Units.

Shared by NobleBlocks on Sep 1, 2021 • 12:00 AM UTC

Authors:

Grotta JC

Yamal JM

Parker SA

Abstract

Background Mobile stroke units (MSUs) are ambulances with staff and a computed tomographic scanner that may enable faster treatment with tissue plasminogen activator (t-PA) than standard management by emergency medical services (EMS). Whether and how much MSUs alter outcomes has not been extensively...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!